Jane Street’s Biostar Pharmaceuticals BSPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-15,556
Closed -$69K – 4925
2016
Q2
$69K Buy
+15,556
New +$34.7K ﹤0.01% 3937
2014
Q4
– Sell
-1,853
Closed -$21K – 3411
2014
Q3
$21K Sell
1,853
-1,598
-46% -$17.8K ﹤0.01% 2465
2014
Q2
$35K Buy
+3,451
New +$38.1K ﹤0.01% 2454

Other funds holding BSPM

Jane Street's BSPM Position: Q3 2016 in Review

Jane Street sold out of Biostar Pharmaceuticals (BSPM) in Q3 2016, closing a stake of 15,556 shares — an estimated $69K sold.

Jane Street first reported a position in BSPM in Q2 2014 and held it in 3 quarters. The position peaked at $69K in Q2 2016. 8 funds tracked by Wall St. Rank hold BSPM as of Q3 2016.

  • Jane Street reported no remaining Biostar Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Jane Street sold 15,556 Biostar Pharmaceuticals shares in Q3 2016, an estimated $69K.
  • Jane Street first reported a position in Biostar Pharmaceuticals in Q2 2014 and held it in 3 quarters.
  • Jane Street's Biostar Pharmaceuticals position peaked at $69K in Q2 2016.
  • 8 funds tracked by Wall St. Rank held Biostar Pharmaceuticals as of Q3 2016.

Based on Jane Street's 13F filing for Q3 2016, filed 15 Nov 2016.